相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations
Zachary S. Zumsteg et al.
CLINICAL CANCER RESEARCH (2016)
Evaluation of individual sensitivity of head and neck squamous cell carcinoma to cetuximab by short-term culture of tumor slices
Marine Peria et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts
Hua Li et al.
MOLECULAR CANCER RESEARCH (2016)
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer
J. J. Morton et al.
ONCOGENE (2016)
Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies
Jerome Donnadieu et al.
BMC CANCER (2016)
Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancer
Annette Affolter et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Study results of primary therapy for head and neck tumors. Highlights of the 2016 ASCO Annual Meeting
A. Gliese et al.
HNO (2016)
Preclinicalmodels to establish innovative therapy strategies. Ex-vivo assessment of head and neck tumor chemo- and immune responses
G. Wichmann et al.
HNO (2016)
Immunotherapeutic studies of head and neck tumors. Highlights of the 2016 ASCO Annual Meeting
C-J. Busch et al.
HNO (2016)
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial
Stefano Maria Magrini et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts
John W. Cassidy et al.
CANCER RESEARCH (2015)
Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384
Andrew J. Leiker et al.
CLINICAL CANCER RESEARCH (2015)
Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications
Francesco Perri et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Immunotherapy of head and neck tumors. Highlights of the ASCO Meeting 2015
S. Laban et al.
HNO (2015)
Treatment of head and neck squamous cell carcinoma recurrences and distant metastases. Highlights of the ASCO Meeting 2015
L. Bussmann et al.
HNO (2015)
The most important study results concerning nonsurgical primary treatment of locally advanced head and neck cancer. Highlights of the ASCO Meeting 2015
A. Gliese et al.
HNO (2015)
Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Assuntina G. Sacco et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Spherical Cancer Models in Tumor Biology
Louis-Bastien Weiswald et al.
NEOPLASIA (2015)
Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review
Amy J. C. Dohmen et al.
CANCERS (2015)
Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma
Christian Freudlsperger et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option
Konrad Klinghammer et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cisplatin, Cetuximab, and Radiation in Locally Advanced Head and Neck Squamous Cell Cancer: A Retrospective Review
Prakash Peddi et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2015)
Lessons from patient-derived xenografts for better in vitro modeling of human cancer
Stephen Yiu Chuen Choi et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Three-dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo
John A. Hickman et al.
BIOTECHNOLOGY JOURNAL (2014)
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
M. M. Gerlach et al.
BRITISH JOURNAL OF CANCER (2014)
Genomic Analysis of Head and Neck Squamous Cell Carcinoma Cell Lines and Human Tumors: A Rational Approach to Preclinical Model Selection
Hua Li et al.
MOLECULAR CANCER RESEARCH (2014)
Characterization of squamous cell carcinoma in an organotypic culture via subsurface non-linear optical molecular imaging
Christina S. Scanlon et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
Arlene A. Forastiere et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers
Shaohua Peng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Exploiting the Head and Neck Cancer Oncogenome: Widespread PI3K-mTOR Pathway Alterations and Novel Molecular Targets
Ramiro Iglesias-Bartolome et al.
CANCER DISCOVERY (2013)
The molecular pathogenesis of head and neck squamous cell carcinoma
S. Michael Rothenberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Integrating Macrophages into Organotypic Co-Cultures: A 3D In Vitro Model to Study Tumor-Associated Macrophages
Nina Linde et al.
PLOS ONE (2012)
Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma
H. E. Colley et al.
BRITISH JOURNAL OF CANCER (2011)
ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE EXTRACELLULAR SIGNAL-RELATED KINASE IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS AFTER IRRADIATION AS PART OF A RESCUE MECHANISM
Annette Affolter et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
Chao Chen et al.
PLOS ONE (2011)
GENOMIC INSTABILITY IN CANCER Strategies to improve radiotherapy with targeted drugs
Adrian C. Begg et al.
NATURE REVIEWS CANCER (2011)
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
James A. Bonner et al.
LANCET ONCOLOGY (2010)
Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells
Sarah E. Golding et al.
CANCER BIOLOGY & THERAPY (2009)
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
Vincent C. Daniel et al.
CANCER RESEARCH (2009)
In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase
Eun Joo Chung et al.
CLINICAL CANCER RESEARCH (2009)
A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration
Thomas K. Hoffmann et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
From Human to Mouse and Back: Tumorgraft Models Surge in Popularity
Ken Garber
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition
Hendrik Fischer et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis
K. W. Kross et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases
Su Young Kim et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner
B Guleng et al.
CANCER RESEARCH (2005)
Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
DJ Adelstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Signal transduction pathways: The molecular basis for targeted therapies
SP Ethier
SEMINARS IN RADIATION ONCOLOGY (2002)
c-jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin
A Szabowski et al.
CELL (2000)
分享论文
